Embecta Corp. - Common Stock (EMBC)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Aug 22, 2026Investment Snapshot
- Trading 84% below Graham Number ($21.01) — significant margin of safety
- Piotroski F-Score 6/9 — moderate financial health
- Strong ROE of 69.8% with 10.2% net margin
- High dividend yield of 14.0%
Embecta Corp. - Common Stock (EMBC) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $186 million . Key value metrics: P/E ratio 1.7, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Embecta Corp. - Common Stock — Fundamental Analysis Summary
Embecta Corp. - Common Stock (EMBC) is trading 84% below its Graham Number of $21.01 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 1.7x.
On financial health, EMBC shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 69.8% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for EMBC is 100/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EMBC reports a high gross margin of 60.9% (sector average: 37.4%) and a strong operating margin of 24.9%.
EMBC shows revenue declining at 4% year-over-year, with earnings growing at 22%.
EMBC pays a high dividend yield of 14.0%.